Figures & data
Figure 1. Overview of the reported discoloration of the hands. A total of 93 935 subjects completed the questionnaire, of whom 10.6% reported monophasic discoloration. Of the subjects who reported monophasic discoloration, 4.2% also reported biphasic or triphasic discoloration. CTD, connective tissue disease
![Figure 1. Overview of the reported discoloration of the hands. A total of 93 935 subjects completed the questionnaire, of whom 10.6% reported monophasic discoloration. Of the subjects who reported monophasic discoloration, 4.2% also reported biphasic or triphasic discoloration. CTD, connective tissue disease](/cms/asset/416c4d2d-d842-4c83-980a-e95f7e8d60a6/irhe_a_1780310_f0001_b.gif)
Table 1. Patient characteristics of the total group, and participants with and without Raynaud’s phenomenon (RP)
Figure 2. Prevalence (95% confidence intervals) of Raynaud’s phenomenon (RP), in the different age groups, shown for men and women
![Figure 2. Prevalence (95% confidence intervals) of Raynaud’s phenomenon (RP), in the different age groups, shown for men and women](/cms/asset/dfaf98da-e780-48ec-a11e-13be63d4fe2f/irhe_a_1780310_f0002_b.gif)
Figure 3. (A) Univariate and (B) multivariate analysis of the relationship between the presence of Raynaud’s phenomenon and low body weight, involuntary weight loss, body weight (kg), low-carbohydrate diet, low-fat diet, and low-calorie intake, shown for men and women. In the multivariate analysis we corrected for creatinine level (as a surrogate measure of muscle mass), daily caloric intake, age, known connective tissue disease., smoking, and use of medication (i.e. beta-blocking agents, immunosuppressive drugs, and central-acting sympathomimetics). In women, we additionally corrected for hormonal status (pre- vs post-menopausal, receiving hormonal contraception, receiving hormonal treatment other than contraception)
![Figure 3. (A) Univariate and (B) multivariate analysis of the relationship between the presence of Raynaud’s phenomenon and low body weight, involuntary weight loss, body weight (kg), low-carbohydrate diet, low-fat diet, and low-calorie intake, shown for men and women. In the multivariate analysis we corrected for creatinine level (as a surrogate measure of muscle mass), daily caloric intake, age, known connective tissue disease., smoking, and use of medication (i.e. beta-blocking agents, immunosuppressive drugs, and central-acting sympathomimetics). In women, we additionally corrected for hormonal status (pre- vs post-menopausal, receiving hormonal contraception, receiving hormonal treatment other than contraception)](/cms/asset/03bf7566-1c50-45ef-a256-f61bc8ce1e91/irhe_a_1780310_f0003_b.gif)